Neuromuscular Blocker

Card Set Information

Author:
ghrelin23187
ID:
227178
Filename:
Neuromuscular Blocker
Updated:
2013-07-15 14:00:26
Tags:
system
Folders:

Description:
neumuscular blocker
Show Answers:

Home > Flashcards > Print Preview

The flashcards below were created by user ghrelin23187 on FreezingBlue Flashcards. What would you like to do?


  1. HAZARDS OF DEEP ANESTHESIA
    • ¢In order to achieve muscle relaxation and
    • abolition of reflexes sufficient for deep surgery, dangerous levels of
    • anesthesia are required.

    • ¢This often led to patient death on the
    • operating table.
  2. HAZARDS OF LIGHT ANESTHESIA
    pt could wake up
  3. TUBOCURARINE - what kind of drug
    paralyzing drug or neuromuscular blocking drug
  4. Tubocurarine - mechanism
    block neuromuscular junction
  5. The Muscle End Plate has what?
    • packed with acetylcholine receptors
    • ¢nicotinic acetylcholine receptors
  6. Mechanism of ms contraction at the neuromuscular junction
    • ¢Nerve impulse travels down the nerve
    • fiber and its branches to the terminal.

    • ¢Depolarization opens presynaptic calcium
    • channels in membrane → inward calcium flux.

    • ¢Calcium promotes discharge of vesicles
    • full of acetylcholine from terminal into synaptic cleft
  7. Neuromuscular junction - components
    cholinesterase, Voltage-gated Ca2+ channel, Ligand-gated Ca2+ channel, Vesicle filled with Ach
  8. ACETYLCHOLINE RECEPTORS
    • Nicotinic Receptors
    • —Ligand Gated Ion Channels
    • —NMJ (NM): Skeletal Muscle (Single Subtype)
    • —Autonomic Ganglia (NN): (Several Subtypes)
    • —CNS: (Multiple Subtypes)

    • Muscarinic Receptors
    • —G Protein-linked Receptors
    • —Postganglionic Parasympathetic
    • CNS, A Few Sympathetic Sites
    • —Receptor Subtypes: M1-5
  9. Muscurinic receptor are predominantly under parasympathetic control. The exception are
    sweat gland under sympathetic control
  10. True or false

    THE NICOTINIC ACETYLCHOLINE RECEPTOR:
    Ligands at the receptor need to be cations.
    true
  11. Almost all agonists and antagonists to nicotinic Ach recptor are ... compound
    quaternary ammonium compounds
  12. THE NICOTINIC RECEPTOR - morphology
    • ¢The receptor is a rosette of five
    • sub-units

    ¢In muscle there are four types, with the α-subunit repeated twice. 

    • ¢In nerve there may only be α-subunits, or a mixture of  α and β
    • subunits.
  13. NONDEPOLARIZING BLOCKERS
    Tubocurarine (and other curariform drugs) are antagonists at the nicotinic receptor.
  14. Tubocurarine - mechanism
    • ¢They compete with released acetylcholine
    • to prevent any end plate depolarization being large enough to activate muscle
    • contraction.
  15. Tubocurarine cause what kind of paralysis?
    flacid in all ms.

    Require blocking enough receptor so that the ms become weak and flaccid.
  16. Tubocurarine - dose response curves and explain?
    very steep because AP is all or none so it require a lot of drug to stop all or most AP in order for ms to become paralyze
  17. PROBLEMS WITH TUBOCURARINE
    • ¢It blocks autonomic ganglia
    • —Lossof control of blood pressure

    • ¢It affects muscarinic receptors
    • —Loss of parasympathetic control of heart rate
    • —Tachycardia

    • ¢It releases histamine
    • —Hypotension and bronchoconstriction

    • ¢Its duration of action is over 30 min
    • —Too long for short procedures such as intubation.

    • ¢Therefore, better drugs had to be
    • developed.
  18. RECEPTOR RESERVE
    • ¢High percentage of receptors must be
    • blocked before any effect on contraction due to receptor reserve

    —Need to block 70% before any effect

    —> 90% for full effect

    • ¢This is:
    • —Greatest in the muscles of respiration
    • —Great in muscles of coarse movement (e.g. gastrocnemius)
    • —Least in the muscles of the face and eyes

    • ¢Lack of facial expression and ptosis are
    • diagnostic of neuromuscular failure.
  19. COMMONLY USED NEUROMUSCULAR (NM)
    BLOCKERS
    • ¢Nondepolarizing
    • —Curare (d-tubocurarine, original blocker)
    • —Vecuronium (“pure” NM blocker)
    • —Rocuronium (most popular)
    • —Cisatracurium (Hofmann elimination)

    • ¢Depolarizing
    • —Succinylcholine

    ¢
  20. Nondepolarizers - mechanism of action
    —Competitive antagonists of nicotinic receptors

    • —Tend to be slow in onset because need receptor block of 70% before any effect, and
    • > 90% for full effect

    • —Two structural types:
    • ¢Aminosteroids
    • ¢Benzylisoquinoliniums
  21. Structure of nondepolarizer
    big so that it will block the neuroms jxn
  22. Structure of depolarizer
    look just that Ach so that it cause depolarization but it can't be degraded by normal esterase --> worn out the ms
  23. DEPOLARIZING BLOCKING AGENTS - Succinylcholine
    —Rapid stimulation of nicotinic receptors

    • —Resistant to acetylcholinesterase, but susceptible to plasma cholinesterase
    • (pseudocholinesterase)

    —Initial depolarization of muscle seen as fasciculation and twitches at onset
  24. DEPOLARIZING BLOCKING AGENTS - Voltage-gated sodium channels
    • are first activated and then inactivated
    • by the depolarization.
  25. DEPOLARIZING BLOCKING AGENTS - mechanism
    • ¢Inactivated channels must first be
    • repolarized before they return to resting state and can be activated again.

    • ¢Prolonging the depolarization by using a
    • relatively longer acting agonist drug prevents return to the resting state.

    • ¢No more action potentials: muscle is then
    • paralyzed even though receptors are activated.
  26. SUCCINYLCHOLINE: ADVANTAGES
    —Rapid onset – 1 min

    —Short duration of action (3 – 5 min)

    • —Inactivation of surrounding Na+ channels    
    • (phase 1 block)
  27. Succinylcholine drip
    achieve long duration of action
  28. Succinylcholine: disadvantages
    —Continuous administration leads to long duration (phase II block)

    —Postoperative muscle pain (from fasciculation

    • —Hyperkalemia (from fasciculation) --> stop the heart 
    • -->—Patients with congenital deficiency of plasma cholinesterase experience long lasting block.
  29. PHARMACOLOGIC/ADVERSE EFFECTS
    OF NEUROMUSCULAR BLOCKERS
    ¢Motor paralysis

    ¢Ganglionic blockade (curare)

    • ¢Histamine release with isoquinoliniums
    • —Hypotension
    • —Bronchospasm

    • ¢Changes in heart rate
    • —Tachycardia with steroidals
    • —Bradycardia with succinylcholine

    ¢Hyperkalemia (succinylcholine)

    ¢Allergic reactions

    ¢Malignant hyperthermia (succinylcholine)
  30. Succinylcholine along cause malignant hyperthermia
    rare but possible
  31. Succinylcholine + volatile inhalation anesthetics cause
    magninant hyperthermia
  32. Malignant hyperthermia - physiological consequence and response
    altered ryanodine receptor magnifies Ca2+ release 

    hypermetabolic response
  33. THERAPEUTIC USES OF NMBs
    ¢Surgery: nondepolarizers & succinylcholine

    ¢Intubated patients in ICU: nondepolarizers

    ¢Tetanus: nondepolarizers

    ¢Joint, bone manipulations: nondepolarizers

    ¢Laryngospasm: succinylcholine & rocuronium
  34. OTHER AGENTS AFFECTING NEUROMUSCULAR TRANSMISSION
    • ¢Diazepam (Valium)
    • —GABAA activation at spinal cord level

    • ¢Antispastics
    • —Baclofen (Lioresal)
    •       ¢Presynaptic GABAB activation →↓glutamate release
    • —Tizanidine (Zanaflex)
    •        ¢α2 agonist: CNS acting 

    • ¢Botulinum toxin (Botox)
    • —Prevents release of Ach by interfering with neurotransmitter vesicle fusion to presynaptic nerve terminal and thus exocytosis of ACh

    —
  35. GANGLIONIC (NN) BLOCKERS - —Trimethaphan
    • ¢Intravenous drug
    • ¢Hypertensive emergencies
    • ¢Intraoperative blood pressure reduction
  36. GANGLIONIC (NN) BLOCKERS-—Mecamylamine
    ¢Oral drug (lipid soluble)

    ¢Refractory hypertension

What would you like to do?

Home > Flashcards > Print Preview